Discovery of <i>N</i>-((3<i>R</i>,4<i>R</i>)-4-Fluoro-1-(6-((3-methoxy-1-methyl-1<i>H</i>-pyrazol-4-yl)amino)-9-methyl-9<i>H</i>-purin-2-yl)pyrrolidine-3-yl)acrylamide (PF-06747775) through Structure-Based Drug Design: A High Affinity Irreversible Inhibitor Targeting Oncogenic EGFR Mutants with Selectivity over Wild-Type EGFRSimon Planken, Jennifer Lafontaine, Louise Bernier et al.|Journal of Medicinal Chemistry|2017Cited by 90
N-(Pyridin-2-yl) arylsulfonamide inhibitors of 11β-hydroxysteroid dehydrogenase type 1: Discovery of PF-915275Michael Siu, Jennifer E. Vogel, Theodore Johnson et al.|Bioorganic & Medicinal Chemistry Letters|2009Cited by 45
N-(Pyridin-2-yl) arylsulfonamide inhibitors of 11β-hydroxysteroid dehydrogenase type 1: Strategies to eliminate reactive metabolitesSajiv K. Nair, Deepak Dalvie, Jean Matthews et al.|Bioorganic & Medicinal Chemistry Letters|2013Cited by 11
CCDC 1541947: Experimental Crystal Structure DeterminationSimon Planken, Jennifer Lafontaine, Douglas C. Behenna et al.|The Cambridge Structural Database|2017Cited by 0